# AptarGroup, Inc. (ATR)

**Exchange:** NYSE  
**Sector:** Healthcare  
**Market cap:** $7.78B  
**Price:** $116.54 (+1.63%)

> AptarGroup, Inc. is a global leader in designing and manufacturing drug delivery, consumer product dispensing, and active material science solutions for pharmaceutical, beauty, personal care, home care, food and beverage, and fragrance markets. The company operates through three primary segments: Pharma, which focuses on specialized packaging and delivery systems including injectables for biologics, GLP-1 therapies, and central nervous system treatments; Beauty and Home, providing dispensing systems like pumps, aerosol valves, and closures; and Food and Beverage, offering sealing and active packaging solutions. AptarGroup serves diverse end markets with innovative technologies for dosing, dispensing, and protection, supporting prescription drugs, consumer health care, color cosmetics, and facial skincare. Its products emphasize precision, reliability, and sustainability, catering to global needs in healthcare and consumer goods. Founded in 1940 and headquartered in Crystal Lake, Illinois, AptarGroup maintains manufacturing facilities across North America, Europe, Asia, and South America.

## Income Statement (Annual, USD)

| Fiscal Year | Revenue | Gross Profit | Operating Income | Net Income | EPS (dil.) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $3.78B | — | $501M | $393M | — |
| 2024 | $3.58B | — | $496M | $375M | — |
| 2023 | $3.49B | — | $404M | $284M | — |
| 2022 | $3.32B | — | $379M | $239M | — |
| 2021 | $3.23B | — | $347M | $244M | — |
| 2020 | $2.93B | $906M | $339M | $214M | — |
| 2019 | $2.86B | $874M | $372M | — | — |
| 2018 | $2.76B | $796M | $286M | — | — |
| 2017 | $2.47B | $723M | $323M | — | — |
| 2016 | $2.33B | $687M | $314M | — | — |
| 2015 | $2.32B | $680M | $324M | — | — |
| 2014 | $2.60B | $696M | $306M | — | — |
| 2013 | $2.52B | $666M | $285M | — | — |
| 2012 | $2.35B | $607M | $259M | — | — |
| 2011 | $2.36B | $637M | $287M | — | — |

## Balance Sheet (Annual, USD)

| Fiscal Year | Total Assets | Total Liabilities | Equity | Cash | Long-term Debt |
| --- | --- | --- | --- | --- | --- |
| 2025 | $5.25B | $2.58B | $2.67B | $402M | — |
| 2024 | $4.43B | $1.96B | $2.47B | $224M | — |
| 2023 | $4.45B | $2.15B | $2.31B | $224M | — |
| 2022 | $4.20B | $2.15B | $2.05B | $142M | — |
| 2021 | $4.14B | $2.17B | $1.97B | $123M | — |
| 2020 | $3.99B | $2.14B | $1.85B | $300M | — |
| 2019 | $3.56B | $1.99B | $1.57B | $242M | — |
| 2018 | $3.38B | $1.96B | $1.42B | $262M | — |
| 2017 | $3.14B | $1.83B | $1.31B | $713M | — |
| 2016 | $2.61B | $1.43B | $1.17B | $466M | — |
| 2015 | $2.44B | $1.29B | $1.15B | $490M | — |
| 2014 | $2.44B | $1.33B | $1.10B | $400M | — |
| 2013 | $2.50B | $1.02B | $1.48B | $310M | — |
| 2012 | $2.32B | $945M | $1.38B | $230M | — |
| 2011 | $2.16B | $870M | $1.29B | $378M | — |

## Cash Flow (Annual, USD)

| Fiscal Year | Operating Cash Flow | CapEx | Free Cash Flow |
| --- | --- | --- | --- |
| 2025 | $570M | $270M | $300M |
| 2024 | $643M | $276M | $367M |
| 2023 | $575M | $312M | $263M |
| 2022 | $479M | $310M | $168M |
| 2021 | $363M | $308M | $56M |
| 2020 | $570M | $246M | $324M |
| 2019 | $514M | $242M | $272M |
| 2018 | $314M | $211M | $102M |
| 2017 | $325M | $157M | $168M |
| 2016 | $325M | $129M | $196M |
| 2015 | $324M | $149M | $174M |
| 2010 | $262M | $119M | $143M |
| 2009 | $294M | $145M | $149M |
| 2008 | $270M | $204M | $67M |

Source: [CompaniesByCap](https://companiesbycap.com/company/ATR)